Aug 21, 2024 / 03:00PM GMT
Matthew Perraton - Theralase Technologies Inc - Independent Chairman of the Board
Good morning, everyone. My name is Matthew Perraton, and I will be hosting the Theralase Technologies Inc., quarterly investor conference call today. Today's call will focus on a presentation and discussion of the Company's second quarter 2024 interim financial statements and our Phase two bladder cancer clinical study results, followed by a question and answer period for each.
The agenda for the call today will be first a presentation by Kristina Hachey, Chief Financial Officer of Theralase on the second quarter interim financial statements, followed by a question-and-answer period regarding the results. Second, once the review of the financial statements has been completed. RRoger Dumoulin-White, President and Chief Executive Officer of Theralase, will provide us an update on the Phase two bladder cancer clinical study also followed by a question-and-answer period regarding the results.
Before we begin, I would like to remind everyone that today's presentation may contain forward-looking statements
Q2 2024 Theralase Technologies Inc Earnings Call Transcript
Aug 21, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers